Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/29/17 → 11/29/18 |
Funding
- Vertex Pharmaceuticals Incorporated (Prot #VX17-661-901)
Prot #VX17-661-901: Tezacaftor/Ivacaftor Combination Therapy Expanded Access Program for Patients 12 Years of Age and Older With Cystic Fibrosis
- Jain, Manu (PD/PI)
Project: Research project